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Background: Endovascular aneurysm repair (EVAR) is still now a controversial technique, which remains
the subject of a number of prospective randomised trials. Although questions remain regarding its long-
term durability, objective evidence exists which demonstrates its reduced physiological impact
compared with conventional open repair, especially for older population and for the concomitant
treatment of aortic abdominal aneurysm (AAA) and abdominal neoplas, such as colo-rectal cancer (CRC).
In these patients it may reduce the high perioperative mortality. Patients and methods: Abdominal
aortic aneurysm and colo-rectal neoplasm are occasionally discovered concurrently. Simultaneous
operative treatment may be in these cases an effective management strategy, alternative to a staged
procedure. The medical record of three consecutive patients undergoing mini-invasive colectomy for
cancer and abdominal aortic aneurysm repair were reviewed. Data collected included mode of presen-
tation, preoperative evaluation, colo-rectal pathology and in-hospital morbidity and mortality. Long term
follow-up was obtained through ofﬁce records and telephone contact. Results: In one patient a
asymptomatic colo-rectal mass was identiﬁed in the course of CT-scan evaluation for AAA; in the other
two patients AAA was discovered during CT-scan oncological evaluation for symptomatic CRC. All pa-
tients underwent successfully concomitant repair of AAA and CRC by means of EVAR procedure and
mini-invasive colo-rectal resection. Pathology revealed adenocarcinomas in all three cases. Perioperative
follow-up revealed minor postoperative complications. Two years follow-up showed no cases of graft
infection, and no interference of vascular procedure on oncological course of the colo-rectal
malignancies.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
With advancing age, the diagnosis of AAA and CRC increases in
frequency. The incidence of synchronous AAA and CRC is rare
(0.5e2% in most series [1,2]), but the management of this clinicalAmato), espogiov@unina.it
na@libero.it (R. Compagna),
o85@gmail.com (T. Bianco),
o@gmail.com (M. Amato),
).
by Elsevier Ltd. All rights reservedsituation remains perplexing and controversial. Careful clinical
decision-making is required regarding which lesion to resect ﬁrst,
whether to resect both lesions at the same time and what to do
when one lesion is an unexpected ﬁnding during elective or
emergent resection of the other. Treating CRC ﬁrst may lead to
increased risk of rupture of AAA in the perioperative period [3]. It
may also theoretically increase the rate of graft infection if AAA
repair is done soon after bowel surgery [2]. Resection of AAA ﬁrst
may lead to signiﬁcant delay of CRC treatment, which involves not
only the operative resection of tumour but adjuvant (and nowadays
neo-adjuvant) treatment as well. Concomitant treatment of both
lesions has been described and has been successful [4]. The.
List of abbreviations
EVAR endovascular aneurysm repair
AAA aortic abdominal aneurysm
CRC colo-rectal cancer
CEA carcinoembryonic antigen
CT-A computed-tomographyangiography
ASA American Society of Anesthesiologists
EG endograft
Table 2
Characteristics of CRC.
Sex Age CRC location TNM R-status Treatment
Male 76 Sigma T1N0M0 R0 Laparoscopic sigma resection
Male 73 Sigma T2N0M0 R0 Laparoscopic sigma resection
Male 82 Rectum T3N0M0 R0 Laparoscopic colo-rectal resection
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endovascular techniques for AAA and aorto-iliac aneurysm repair
may add new options for the treatment of synchronous lesions. We
report three cases of successful treatment of aneurysmal disease
and CRC using endovascular techniques and mini-invasive colo-
rectal resection.
2. Patients and methods
A retrospective review of the records of patients with colo-rectal
oncologic disease and AAA was performed from 2009 to 2012.
Among 62 patients (56 male and 6 female, ranging in age from 54
and 88 years, with a mean age of 74 years) with abdominal aortic
aneurysm admitted during that period to our department for
elective surgery, 3 of them (4.83%) had also synchronous colo-rectal
cancer. One of them could be deﬁned in type I of Szilagyi Classiﬁ-
cation (because the aneurysm was discover pre-operatively after
the cancer); while the other two case may be considered as type II
of Szilagyi Classiﬁcation (because AAA and CRC were discovered at
the same time pre-operatively). No AAA was discovered intra-
operatively, during cancer surgery (Type III) or during AAA surgery
(Type IV). So we have been considering a group of three patients
with synchronous CRC and AAA. Mean age was 73 years, and all
patients were men. Two patients were symptomatic for CRC and
one asymptomatic. In Table 1, the data regarding the AAA are
shown, whereas in Table 2, the data regarding characteristics of CRC
of all patients are presented.
2.1. Case 1
A 76-year-old male underwent colonoscopy after complaining
of change in bowel habits along with rectal bleeding; colonoscopy
revealed an irregular vegetant lesion involving half of the circum-
ference of the sigmoid colon. Biopsy revealed a tubule-villous ad-
enoma with areas of cancer degeneration. The carcinoembryonic
antigen (CEA) and circulating tumor-associated antigen (CA 19.9)
were within a normal range. Clinical examination did not reveal a
pulsatile abdominal mass, but the thoraco-abdominal computed-
tomographyangiography (CT-A) performed as part of the preoper-
ative staging workup showed a 43-mm fusiform infrarenal AAA
without involvement of the aortic bifurcation and a 32-mm fusi-
form left common iliac artery aneurysm. There was no liver or lung
metastases. No hypercoagulable disorder was documented. Amer-
ican Society of Anesthesiologists (ASA) score was class II. AnatomicTable 1
Characteristics of aneurysms.
Sex Age AAA Diam. (cm) Treatment
Male 76 4,3 Fusiform infrarenal þ 3,2 left common
iliac artery
Biforcated infrarenal
aortic EG
Male 73 5,4 infrarenal Biforcated infrarenal
aortic EG
Male 82 3,2 left common iliac aneurysm Iliac endograftcriteria for endograft (EG) placement were met and informed
consent for a synchronous procedure was obtained. A bifurcated
infrarenal EG (Excluders 26 mmdW.L. Gore & ass. Inc., USA) was
implanted through a conventional surgical exposure of the right
common femoral artery with a controlateral percutaneous trans-
femoral approach; a completion angiogram showed the successful
deployment of the EG, the complete exclusion of the both the an-
eurysms, the patency of the renal and hypogastric arteries, and no
endoleak. During the same operation, a laparoscopic sigma resec-
tion was performed in standard fashion.
The histological examination of the sigmoid lesion conﬁrmed a
pT1 G2 adenocarcinoma, beyond the muscolaris propria but no
penetrating the peritoneum. The resection margins were free of
malignancy. Lymphnodes showed no metastatic involvement. The
patient had an uncomplicated recovery and was discharged home 6
days after the intervention. Six, twelve and twenty-four month
follow-up CT-A showed the persistent exclusion of the aneurysms
without endoleak, no EG-related complication, no sign of graft
infection and the absence of malignant recurrency.
2.2. Case 2
A 73-year-old male underwent CT-A scan for a pulsatile
abdominal mass after a routine abdominal echography for vague
abdominal pain. This revealed an infrarenal AAA measuring 5.4 cm
in diameter. This revealed also a lesion on the sigmoid colon. Biopsy
at colonoscopy showed a moderately differentiated adenocarci-
noma. Criteria for placement of an endograft were met. The patient
underwent a successful placement of an aorto-bis iliac endograft
(Excluders 26 mmdW.L. Gore & ass. Inc., USA). During the same
procedure, the patient underwent a resection of the sigmoid colon,
by means laparoscopic procedure. The pathologic diagnosis of the
sigmoid lesion was that of a T2N0MO adenocarcinoma. The patient
had an uncomplicated recovery and was discharged home after 7
days. At 6, 12 and 24 months follow-up there have been no
complications.
2.3. Case 3
A 82-year-old male underwent an abdominal A-CT scan for
abdominal pulsation: a 3.2 cm left common iliac aneurysm was
discovered. A lesion in the proximal rectumwas also visualised and
then biopsied at colonoscopy. Biopsy shown a moderately differ-
entiated adenocarcinoma. Criteria for placement of an iliac
endograft and concomitant laparoscopic colo-rectal resection were
met. The patient underwent placement of an endograft (Excluders
12 mmdW.L. Gore & ass. Inc., USA) followed by a colo-rectal
resection during the same operation. The pathologic diagnosis of
the rectal lesion was that of a T3N0M0 adenocarcinoma. The pa-
tient had an uncomplicated recovery and was discharged home
after 9 days. At 6e12 and 24 months follow-up there have been no
mayor complications.
3. Results
Management of concurrent disease was standard, regarding
sequence and timing of operations: all patients underwent
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with laparoscopic procedure, during the same period of hospitali-
zation, with a three-day interval between the two procedures. The
decision to proceed ﬁrst with the vascular disease was suggested
both from its severity, and also mostly to prevent that heparin-
ization, which is required by the endovascular procedure, could
cause late bruising or bleeding at the level of previous intestinal
anastomoses: heparin was infact used during endovascular pro-
cedures and then stopped in all patients.
The procedures for the application of endovascular stent graft
required respectively 180, 205 and 195min, and all were conducted
under spinal anesthesia with sedation. The duration of the in-
terventions performed for colo-rectal cancer by laparoscopic sur-
gery, in each case after three days of the endovascular procedure,
required respectively 220, 190 and 230 min. All patients treated by
laparoscopic colo-rectal surgery underwent successfully general
anesthesia.
The preoperative bowel preparation has not been modiﬁed in
any case from the previous procedure of spinal anesthesia, or from
drugs used for the previous endovascular procedure.
The recovery of the bowel canalizationwas normal (36e72 h) in
all three patients following surgery for resection of colo-rectal
cancer. There were no dehiscence of intestinal anastomoses, nor
hematomas were observed in the course of laparoscopic surgery in
the retroperitoneal region. There were no wound infections in any
of the procedures performed and there were no major complica-
tions related to the two minimally invasive procedures performed
in the patients observed, neither during the period of hospitaliza-
tion, nor in the subsequent follow-up.
4. Discussion
While there are ample, anecdotal reports of synchronous and
staged treatments of AAA and rectal cancer, there is no evidence of
the uniform superiority of one approach. Treating the AAA and
cancer simultaneously raises the concern of either bacterial seeding
of the graft or the risks associated with prolonged operative time.
The arguments against this are that with appropriate bowel prep-
aration, perioperative antibiotics and meticulous operative and
anesthetic technique, these complications are avoidable.
Those supporting a synchronous approach cite [1]. avoiding the
risks of a second, major operation and [2]. obviating the risk of
aneurysm rupture during recovery from colon surgery. Treating the
cancer ﬁrst with associated chemotherapy further raises the pos-
sibility of chemotherapyrelated AAA growth and rupture [3]. Fixing
the AAA ﬁrst poses a risk of graft infection during subsequent colon
surgery and increases the time to eventual cancer treatment, with
any delay in recovery potentially increasing the complications and
risks associated with cancer growth. In the absence of evidence
supporting a uniform approach to patients with coexistent AAA and
rectal cancer, we acknowledge that decisions tend to be made
based on surgeon experience and what seems most intuitive.
Furthermore, we believe that the recommendations should still
now be strictly individualized.
Aneurysm size (an independent predictor of aneurysm rupture),
cancer stage, patient co-morbidities and life expectancy based on
either co-morbidities or cancer prognosis are all relevant in
informing the management priorities. The AAA should be treated
ﬁrst in a patient with a large AAA and a small, early-stage cancer. If,
however, co-morbidities are prohibitive for the repair of a large
juxtarenal AAA, we would suggest that the small cancer be treated
ﬁrst, and the AAA reassessed based on how the patient tolerates the
colon surgery. Alternatively, in a healthy patient with few co-
morbidities, the coexistence of a pre-obstructing cancer and a
large AAA might merit concomitant treatment of both.Treating the AAA ﬁrst with endovascular techniques followed by
staged CRC resection is an alternative, especially in large aneurysms
suitable for an endograft. In the Lin series, this group of patients had
the lowest perioperative morbidity and mortality (17 and 0%,
respectively) [1].
Treating the CRC ﬁrst, especially with laparotomy, exposes the
patient to the risk of aneurysm rupture in the immediate post-
operative period [3]. This may be secondary to collagen lysis
induced by the operation itself; nutritional depletion and surgical
dissection may also have an effect.
Administration of chemotherapy and radiation therapymay also
induce aneurysm enlargement and rupture [4]. In a review of the
literature, Shalhoub et al. [5] reported an 11% interval AAA rupture
rate in patients treated with CRC resection followed by staged AAA
repair. Treatment of CRC followed by endovascular repair is asso-
ciated with low perioperative mortality rates, but postoperative
sigmoid ischemia has been reported [6]. The authors propose that
evaluation of the vasculature of the colon be undertaken before
treatment of concurrent CRC and AAA. Simultaneous treatment of
both lesions may offer the advantage of no delay between treat-
ments and a single anesthetic. The magnitude of the operation is
increased, however. Prusa et al. reported lower morbidity and
mortality in patients with CRC and AAA treated in one stage versus
two stages (8 and 4.5% vs. 21.3 and 6%, respectively) [7e9]. Endo-
vascular therapy appears suitable for a single-stage procedure.
However, in cases in which open AAA repair is undertaken with
synchronous CRC resection, mortality may be as high as 13% [10].
Single-stage procedures theoretically pose the risk of graft infec-
tion. Several reports have not shown this to be signiﬁcant. In most
series of combined CRC resection and AAA repair, no graft in-
fections were reported [11,12]. Risk of direct graft contamination by
gut organisms might be reduced by a combination of bowel prep-
aration, meticulous surgical technique, and antimicrobial therapy.
In addition, endograft placement should in theory prevent expo-
sure of the graft to a contaminated or infected operative ﬁeld, since
the aneurysmal sac is not opened [13,14].
The use of endovascular techniques has provided a valuable
armamentarium to the surgical treatment of AAA. Short-term
beneﬁts regarding perioperative morbidity and mortality in
elderly are well known. These short-term beneﬁts are important in
patients who require further treatment for concomitant neoplasms.
The long-term complications of endovascular techniques may be of
less importance, since life expectancy may be shorter [15e18].
Finally, with advancing technology and the ever-widening ap-
plications of minimally invasive approaches to both cancer surgery
and aneurysm repair, the treatment paradigms and priorities
should continue to evolve.
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